ARTICLE AUTHORS
ARTICLE INFO
IF: 0.478
Cite Score:
0.54
THOMSON REUTERS - SCOPUS

Ovarian Cancer Staging by MDCT

AUTHORS

Mahrooz Malek 1 , *

AUTHORS INFORMATION

1 Assistant professor of Tehran University of Medical Sciences, Tehran, Iran

ARTICLE INFORMATION

Iranian Journal of Radiology: 14 (Special Issue); e48366
Published Online: April 12, 2017
Article Type: Abstract
Received: December 20, 2016
Accepted: February 7, 2017
DOI : 10.5812/iranjradiol.48366
Crossmark

Crossmark

CHEKING

READ FULL TEXT
Abstract

Ovarian cancer is the most lethal gynecological cancer and about 70% of the patients are advanced stagein the time of diagnosis. Decision about management (surgical debulking versus neoadjuant chemotherapy) in ovarian cancer patients is dependent on initial staging by abdominopelvic MDCT or MRI, so, Radiologist expertise on ovarian cancer staging is very important. Involvement of mesenteric root, peritoneal implante larger than 2 cm, lymphadenopathy superior to renal hilum and implants near hepatic veins are criteria for nonresectability of ovarian cancer and radiologist must be familiar and expert on the imaging protocol and findings on MDCT for ovarian cancer staging.

Keywords

© 2017, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Full Text

Full text is available in PDF

COMMENTS

LEAVE A COMMENT HERE: